We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YELP:NYSEYelp Inc. Analysis

Data as of 2026-09-16 - not real-time

$21.14

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Yelp Inc. trades at $21.14, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Over a rolling month the price has lost 21.1%. Momentum indicators put RSI at 38.2 (approaching oversold) with MACD reading bearish. Recent trading has carved out support near $20.27 and resistance around $24.49.
On valuation the read is undervalued — earnings multiple of 10.6 versus a 15.7 sector average, below the peer group. Sell-side targets cluster 18.9% above the current quote.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 41.6%, a beta of 0.39 and a maximum drawdown of 41.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 4/10 conviction on the long call.

Top Market Events

Updated Aug 6, 2026 0 SAN FRANCISCO-- BUSINESS WIRE --Aug 6, 2026-- Yelp Inc.Yelp Inc YELP delivers robust Q2 2026 results with revenue and adjusted EBITDA exceeding guidance, fueled by AI-driven...As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 25.55
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 10.6 versus sector average of 15.7
  • Trading below the 200-day average of 25.55

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 10.6 versus sector average of 15.7
  • Analyst targets imply +18.9% versus the current price
  • Return on equity of 18.2%

Key Metrics & Analysis

Financial Health

Revenue Growth1.40%
Profit Margin8.59%
P/E Ratio10.6
ROE18.19%
ROA11.43%
Debt/Equity19.13
P/B Ratio1.9
Op. Cash Flow$349.6M
Free Cash Flow$283.7M
Industry P/E15.7

Technical Analysis

TrendBearish
RSI38.2
Support$20.27
Resistance$24.49
MA 20$22.39
MA 50$24.36
MA 200$25.55
MACDBearish
VolumeIncreasing
Fear & Greed Index91.09

Valuation

Fair Value$67.92
Target Price$25.13
Upside/Downside18.85%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.39
Volatility41.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.